Published in the Annals of Internal Medicine October 18, 2010 vol. 153 no. 8 532-535
What's in Placebos: Who Knows? Analysis of Randomized, Controlled Trials
Beatrice A. Golomb, MD, PhD; Laura C. Erickson, BS; Sabrina Koperski, BS; Deanna Sack, BS; Murray Enkin, MD; and Jeremy Howick, PhD
University of California, San Diego, School of Medicine, San Diego, California
This paper can be accessed at: http://www.annals.org/content/153/8/532.abstract
How do you know a drug is safe and effective? Because it’s tested against a placebo, or sugar pill, and you know it works if it significantly outperforms the dummy pill. But suppose the sugar pill isn’t as benign as we think – suppose it contains a chemical that makes even a bad drug such as a statin look good?
This study looks at the placebo, a method used in countless drug trials over the years. The researchers studied four of the major medical journals published in 2008 and 2009 – and discovered that hardly any trials listed the ingredients of the placebo.
As the composition of the placebo can have a big effect on a drug trial’s results, the researchers concluded its ingredients should be listed every time.
AMAZON UK $29 Billion Reasons to Lie About Cholesterol: Making Profit by Turning Healthy People into Patients
AMAZON USA $29 Billion Reasons to Lie About Cholesterol: Making Profit by Turning Healthy People into Patients
Tidak ada komentar:
Posting Komentar